A Study of Inhaled AZD8630 in Adolescents With Asthma

Completed · Phase 1

Conditions studied: Asthma

In brief

The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, tolerability, and immunogenicity of single inhaled dose of AZD8630 administered in adolescent participants with asthma as well as the safety and performance of the dry powder inhaler.

Key facts

Study ID

NCT07065331

Run by

AstraZeneca

People needed

10

Starts

2025-06-11

Expected to finish

2025-09-19

Last updated by the study team

2025-10-14

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research Site — Bakersfield, California, United States
• Research Site — Miami Lakes, Florida, United States
• Research Site — Lafayette, Louisiana, United States
• Research Site — Raleigh, North Carolina, United States
• Research Site — Toledo, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Spartanburg, South Carolina, United States
• Research Site — Boerne, Texas, United States
• Research Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.